Ph.D. WEI-WU HE - 27 Jan 2026 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Reporting Managers (7)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
WEI-WU HE, Ph.D.	35%	8,965,535	2,130,550	6,834,985	/s/ Wei-Wu He, Ph.D.	Wei-Wu He, Ph.D.	0001542073
HUIYING MEMORIAL FOUNDATION	3.1%	637,644	0	637,644	/s/ Wei-Wu He, Ph.D.	Wei-Wu He, Ph.D./President
EMERGING TECHNOLOGY PARTNERS, LLC	5.3%	1,097,341	0	1,097,341	/s/ Wei-Wu He, Ph.D.	Wei-Wu He, Ph.D./ Managing Member
ETP Global Fund L.P.	3.7%	753,234	0	753,234	EMERGING TECHNOLOGY PARTNERS, LLC	General Partner
ETP BIOHEALTH III FUND, L.P.	1.5%	300,000	0	300,000	EMERGING TECHNOLOGY PARTNERS, LLC	General Partner
HE Family GRAT	0.5%	100,000	0	100,000	/s/ Wei-Wu He, Ph.D.	Wei-Wu He, Ph.D./Trustee
ETP Global Fund III L.P.	20%	5,000,000	0	5,000,000	/s/ Wei-Wu He, Ph.D.	Wei-Wu He, Ph.D./ Managing Member